QL9
Contact
Management Execution Risk intelligence
See where execution risk is concentrated across your portfolio companies.
MER gives private equity owners and investment companies evidence of organisational execution risks that conventional performance reporting may not reveal.
Through a low opportunity cost survey of managers at business level and below across the organisation, MER identifies patterns affecting decisions, escalation and follow-through against a live value-creation priority.
Contact QL9
For active ownership, acquisitions and integration
MER view
Management execution risk
Execution exposure
Where delivery may become unreliable.
Decision dependencies
Where execution depends on particular decisions, roles or routines.
Verification priorities
What warrants targeted verification
Follow-up priorities
Where stronger control or monitoring may be warranted
From management evidence to execution intelligence.
The problem
MER shows where execution deserves closer scrutiny, even when financial performance and milestone reporting have not yet revealed a problem.
01 —
Collect
A survey across the manager population.
02 —
Analyse
MER identifies where organisational execution risk is concentrated.
03 —
Act on evidence
Owners receive a risk map, targeted verification questions and proposed follow-up.
MER reveals where execution risk is concentrated across the management organisation, giving owners a clearer basis for deciding what to verify.
What MER establishes
Execution exposure
Where management execution may make delivery unreliable.
Decision dependencies
Where delivery depends on particular decisions, roles or operating routines.
Verification priorities
Where execution assumptions warrant targeted verification.
Control priorities
Where stronger control or monitoring may be warranted.
When a value-creation assumption is expensive to get wrong, MER tests whether the organisation’s execution system is reliable enough to carry it.
MER illustration
Company A — Decision dependencies
Verify whether critical decisions depend on a small number of decision-makers.
Company B — Follow-through exposure
Verify what happens to agreed actions when competing priorities intervene.
The next advantage is not another value-creation initiative. It is knowing where execution needs closer verification.
You have seen two.
What would the evidence show across your portfolio?
Where QL9 fits
During active ownership
Understand where organisational execution exposure may affect a current value-creation priority. Direct verification and follow-up where the evidence warrants it.
During acquisitions and integration
Examine execution assumptions relevant to the investment plan and use the findings to guide diligence and post-acquisition follow-up.
From management evidence to execution intelligence
Governance and privacy boundary
MER separates evidence, interpretation and decision use. Findings remain bounded by the available evidence, with explicit limits on what can be concluded and human judgement retained for consequential decisions.
Evidence remains traceable
Interpretation remains bounded
Decision authority remains human
QL9 AB · Stockholm, Sweden
Management Execution Risk intelligence